Bei Jing Shang Bao
Search documents
中国海外发展2025年12月合约物业销售额398.32亿元
Bei Jing Shang Bao· 2026-01-07 11:57
Group 1 - The core point of the article is that China Overseas Development reported a slight decline in contract property sales for December 2025 compared to the previous year, despite an increase in sales area [1] Group 2 - In December 2025, the total contract property sales amount to approximately 39.832 billion yuan, representing a year-on-year decrease of 1% [1] - The corresponding sales area for the same period is approximately 1.3324 million square meters, showing a year-on-year increase of 2.4% [1]
易方达基金:拟将零售直销、基金投顾业务逐步迁移至易方达财富
Bei Jing Shang Bao· 2026-01-07 11:44
Core Viewpoint - E Fund Management has established a wholly-owned subsidiary, E Fund Wealth Management Fund Sales (Guangzhou) Co., Ltd., to enhance its wealth management services and integrate retail direct sales and fund advisory services [1][3] Group 1: Company Structure and Licensing - E Fund Wealth has obtained the Securities and Futures Business License and the qualification for the pilot fund advisory business [1][3] - The establishment of E Fund Wealth is part of a strategy to better serve investors through the integration and upgrade of wealth management services [1][3] Group 2: Business Migration Plan - E Fund plans to gradually migrate its retail direct sales and fund advisory services to E Fund Wealth, allowing personal investors to transfer their holdings to the new subsidiary [1] - Investors can choose to transfer their E Fund-related products to E Fund Wealth while maintaining the same redemption fees, transaction efficiency, and services [1] - A transition period will be set up during which both E Fund and E Fund Wealth will continue to provide announcements to investors [1] Group 3: Advisory Service Transition - Starting from January 23, the fund advisory service providers on 21 cooperative platforms, including Tian Tian Fund and China Merchants Bank, will change from E Fund to E Fund Wealth [2] - All rights and obligations under the advisory service agreements will automatically transfer to E Fund Wealth, which will continue to provide the same services, rules, and fee rates [2]
侃股:热门概念炒作必然会分化
Bei Jing Shang Bao· 2026-01-07 11:43
相反,那些仅仅依靠概念炒作、缺乏核心技术和实际业绩支撑的公司,则逐渐被市场淘汰。随着市场情 绪的降温,投资者纷纷撤离,导致这些公司的股价下跌,甚至可能陷入长期的低迷状态。 热门概念炒作的分化现象,是市场自我调节和优化的过程。它有助于淘汰那些不具备真实价值的公司, 让资源更加集中地流向那些真正有潜力、有实力的上市公司,从而推动整个行业的健康发展。概念炒作 分化也提醒投资者要保持理性,不要被短期的市场热点所迷惑,应注重对上市公司的基本面进行分析和 研究,作出更加明智的投资决策。 对于上市公司而言,也应该进一步加强对于股价波动的监测,当股价发生明显异动时,应该第一时间公 告澄清,避免股价的剧烈波动,这既是一种对投资者负责任的态度,也是增强公司可信度的重要方式。 北京商报评论员 周科竞 在纷纷披露异动公告之后,脑机接口概念股出现分化走势。热门概念的炒作初期往往带有非理性情绪, 导致真假概念股一起被"炒上天",但初期炒作之后,市场情绪逐渐回归理性,真正有核心技术和业绩支 持的公司会继续前行,其他概念股则会逐步被市场淘汰。 不仅仅是脑机接口,任何热门概念的炒作初期,市场情绪往往伴随着非理性。投资者被概念题材所蕴含 的巨大 ...
天宇股份原料药阿帕他胺通过CDE审评
Bei Jing Shang Bao· 2026-01-07 11:17
Core Viewpoint - Tianyu Co., Ltd. announced that its wholly-owned subsidiary, Zhejiang Jingsheng Pharmaceutical Co., Ltd., has recently passed the review by the National Medical Products Administration (NMPA) for the active pharmaceutical ingredient (API) Apalutamide, which is used in prostate cancer treatment [1] Group 1: Company Information - Tianyu Co., Ltd. has a subsidiary named Zhejiang Jingsheng Pharmaceutical Co., Ltd. that specializes in pharmaceutical production [1] - The company is focused on developing Apalutamide, a non-steroidal anti-androgen drug [1] Group 2: Product Details - Apalutamide is indicated for the treatment of prostate cancer, specifically non-metastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer [1] - The drug works by inhibiting the androgen receptor signaling pathway, thereby delaying disease progression [1] - Apalutamide is intended to be used in conjunction with androgen deprivation therapy under medical supervision [1]
昆药集团副董事长李泓燊离任
Bei Jing Shang Bao· 2026-01-07 11:17
北京商报讯(记者 王寅浩 宋雨盈)1月7日,昆药集团发布公告称,因工作调整原因,公司副董事长李 泓燊申请辞去公司十一届董事会副董事长、董事、董事会战略与ESG委员会委员、审计与风险控制委员 会委员职务。辞任后,李泓燊不再担任公司任何职务。 ...
恒瑞医药瑞拉芙普α注射液获批上市
Bei Jing Shang Bao· 2026-01-07 11:17
北京商报讯(记者 王寅浩 宋雨盈)1月7日,恒瑞医药发布公告称,公司子公司苏州盛迪亚生物医药有 限公司收到国家药品监督管理局的通知,批准公司自主研发的1类创新药瑞拉芙普α注射液上市。批准 的适应症为瑞拉芙普α注射液联合氟尿嘧啶类和铂类药物用于经充分验证的检测评估PD-L1阳性 (CPS≥1)的局部晚期不可切除、复发或转移性胃及胃食管结合部腺癌的一线治疗。 ...
未来科学城置业与贝好家合作开发北京昌平能源谷住宅地块
Bei Jing Shang Bao· 2026-01-07 11:04
北京商报讯(记者 李晗)2026年1月7日,北京商报记者了解到,未来科学城置业有限公司(以下简 称"未来科学城置业")与贝好家就北京市昌平区未来科学城东区能源谷板块的CP01-1703-0002、0003住 宅组团地块达成深度合作。值得关注的是,这是贝好家在北京的第四个合作项目,也是与未来科学城置 业的第二次携手。 据了解,上述地块于2025年11月19日由未来科学城置业以底价12.426亿元摘得。出让文件显示,该宗地 块土地面积约为4.3万平方米;规划建筑规模8.22万平方米,用地性质为R2二类居住用地、A2文化设施 用地。 ...
爷爷的农场IPO之殇:30%营销费与3%研发,质量黑洞与洋身份争议
Bei Jing Shang Bao· 2026-01-07 11:04
Core Viewpoint - Grandpa's Farm, a children's food brand embroiled in "pseudo foreign brand" controversy, is seeking to list on the Hong Kong Stock Exchange, showcasing significant revenue growth but facing challenges related to marketing strategies and product quality [1][3]. Financial Performance - The company reported revenues of 622.39 million yuan in 2023, 875.35 million yuan in 2024, and 778 million yuan in the first nine months of 2025, reflecting year-on-year growth rates of 40.64% and 23.15% respectively [3]. - Net profits also increased, with growth rates of 35.97% and 12.07% for the same periods [3]. - Sales and distribution expenses were substantial, reaching 201.26 million yuan, 306.04 million yuan, and 283.03 million yuan, accounting for approximately 32.3%, 35.0%, and 36.3% of total revenue [3]. Marketing Strategy - The company has heavily invested in marketing, spending over 30 million yuan on advertising through more than 30 popular TV dramas and collaborating with well-known IPs and celebrities [5]. - The marketing expenditure is significantly higher than R&D investment, which has remained around 3% of revenue [3][5]. Product and Brand Identity - Grandpa's Farm initially marketed itself as a "Dutch brand," emphasizing European origins, but has since shifted to focus on product quality and nutritional value in its branding [6][7]. - The company employs a global sourcing and local production model, relying on domestic OEM manufacturers for nearly all its products [7]. Quality Issues - The brand has faced multiple quality control issues, with products failing to meet safety standards and receiving regulatory penalties [9][10]. - Consumer complaints have been frequent, with over 200 reported issues related to product quality on complaint platforms [10]. Conclusion - While the company is experiencing rapid growth and has a strong marketing presence, it faces significant challenges regarding product quality, brand identity, and consumer trust as it approaches its IPO [10].
国投白银LOF:因交易价格波动将于1月8日开市起停牌至10时30分
Bei Jing Shang Bao· 2026-01-07 11:04
Core Viewpoint - Guotou Ruijin Fund announced a temporary suspension of trading for its Guotou Ruijin Silver Futures Securities Investment Fund (LOF) due to significant fluctuations in the secondary market price, aiming to protect investor interests [1] Summary by Relevant Sections - **Fund Performance** - As of January 6, the net asset value per unit of the fund was 2.1319 yuan, while the closing price in the secondary market on January 7 was 2.565 yuan, indicating a substantial premium over the net asset value [1] - **Trading Suspension Details** - The fund will suspend trading from January 8, 2026, at the market opening until 10:30 AM, with a possibility of applying for a temporary suspension or extending the suspension if the premium does not decrease effectively [1] - **Investor Warning** - The announcement cautions investors against blindly investing in fund shares with high premium rates, as it may lead to significant losses [1]
因编制虚假的财务报表等,永诚财险陕西分公司、西安中支合计被罚52万元
Bei Jing Shang Bao· 2026-01-07 11:04
北京商报讯(记者 李秀梅)1月7日,陕西金融监管局发布行政处罚信息显示,永诚财产保险股份有限公司陕西分公司、西安中心支公司及相关责任人员, 因未按规定使用经批准或备案的条款费率、编制虚假的财务报表,陕西金融监管局对永诚财险陕西分公司罚款20万元,对永诚财险西安中心支公司罚款27万 元;对毕瀚文警告并罚款2万元,对武威警告并罚款3万元。 | 序号 | 当事人 | 主要违法违规行为 | 行政处罚 | 作 | | --- | --- | --- | --- | --- | | | 名称 | | 内容 | | | | | | 对 永 诚 财 险 | श्रि | | | | | 陕西分公司 | | | | 永诚财产 | | 罚 款 20 万 | | | | 保险股份 | | 元,对永诚 | | | | 有限公司 | 未按规定使用经批 | 财险西安中 | | | | 陕西分公 | 准或备案的条款费 | 心支公司罚 | | | 1 | 司、西安 | 率、编制虚假的财 | 款 27万元; | | | | 中心支公 | 务报表 | 对毕瀚文警 | | | | 司及相关 | | 告并罚款2万 | | | | 责任人员 | | ...